Polatuzumab vedotin–based salvage immunochemotherapy as third-line or beyond treatment for patients with diffuse large B-cell lymphoma: a real-world experience

Yuwen Wang, Xavier Cheng-Hong Tsai, Hsin‐An Hou, Feng‐Ming Tien, Jia‐Hau Liu, Wen‐Chien Chou, Bor‐Sheng Ko, Yu‐Wen Chen, Chien‐Chin Lin, Chieh‐Lung Cheng, Min‐Yen Lo, Yun‐Chu Lin, Li‐Chun Lu, Shang‐Ju Wu, Sung‐Hsin Kuo, Ruey‐Long Hong, Tai‐Chung Huang, Ming Yao